Skip to main content

Advertisement

  • Correction
  • Open Access

Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant

  • 1, 2,
  • 1, 2,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1, 2,
  • 1,
  • 1, 2 and
  • 1, 2Email author
Journal of Hematology & Oncology201912:24

https://doi.org/10.1186/s13045-019-0715-8

  • Received: 26 February 2019
  • Accepted: 27 February 2019
  • Published:

The original article was published in Journal of Hematology & Oncology 2016 9:87

Correction to: J Hematol Oncol (2016) 9:87

https://doi.org/10.1186/s13045-016-0319-5

The original article [1] contains two errors in the MRD Testing sub-section of the Methods:
  1. 1)

    The description, “…by four-color flow cytometry (FCM)” was incorrect. The correct description should be “…by eight-color flow cytometry (FCM)”.

     
  2. 2)

    The description, “LAIPs were detected by four-color FCM” was incorrect. The correct description should be “LAIPs were detected by eight-color FCM”.

     

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University Institute of Hematology, Peking University People’s Hospital, Xi Zhimen South Street No. 11, Beijing, 100044, China
(2)
Collaborative Innovation Center of Hematology, Xi Zhimen South Street No. 11, Beijing, 100044, China

Reference

  1. Yan C-H, et al. Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant. J Hematol Oncol. 2016;9:87. https://doi.org/10.1186/s13045-016-0319-5.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2019

Advertisement